INCR Stock Price, Chart, Stats & News

InterCure Ltd.
Save
53.08M
Market cap
–
Current P/E
6.18x
Forward P/E
INCR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 16.71% |
Operating margin | -29.62% |
Pretax margin | -37.47% |
Net margin | -29.18% |
Effective tax rate | 17.04% |
ROA | -9.44% |
ROE | -17.13% |
D/E | 0.42x |
Interest coverage ratio | -8.08x |
INCR valuation
P/E | – |
P/S | 0.54x |
P/B | 0.31x |
P/CF | 11.13x |
P/FCF | 14.60x |
P/OCF | 11.13x |
PEG | 0.32x |
EV multiple | -0.03x |
About
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil.
Similar securities
Based on sector and market capitalization
Report issue











